Hepatocellular carcinoma (HCC) is one of the deadliest malignant tumors in the world, and its incidence and mortality have increased year by year. HCC research has increasingly focused on ...
Geospatial Genomics: Operationalizing Multilevel Conceptual Frameworks of Cancer Health Outcomes to Account for Gene-Person-Place Relationships The Oncology Grand Rounds series is designed to place ...
BRISBANE, Calif., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology ...
This study investigated the long-term prognosis and clinical course of patients who survived for more than 5 years after hepatocellular carcinoma (HCC) diagnosis.This retrospective cohort study used ...
A newly developed nomogram predicts preoperative microvascular invasion in patients with HCC, improving surgical planning and outcomes.
Transarterial chemoembolization (TACE) improves survival in cirrhotic patients with hepatocellular carcinoma (HCC). The optimal schedule, best anticancer agent and best technique are still unclear.
Candidate genes in canine hepatocellular carcinoma for molecular targeted therapy. BMC Research Notes , 2024; 17 (1) DOI: 10.1186/s13104-024-07016-y Cite This Page : ...
Hepatocellular carcinoma (HCC) is one of the deadliest malignant tumors in the world, and its incidence and mortality have ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback